Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient?

Overview of attention for article published in Drugs & Aging, November 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 17,330 followers.

RT @GRUPOCRONOSSEF1: Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? https://t.co/62sub4BIEQ

RT @DrRaulCordoba: Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? #gerionc #geriheme https://t.co/fHEtZeiidU

RT @GRUPOCRONOSSEF1: Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? https://t.co/62sub4BIEQ

Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? #gerionc #geriheme https://t.co/fHEtZeiidU

RT @GRUPOCRONOSSEF1: Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? https://t.co/62sub4BIEQ

Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? https://t.co/62sub4BIEQ

Novel Cancer Therapeutics in Geriatrics: What is Unique to the Aging Patient? https://t.co/F4zbzyvr8s https://t.co/tcc7Dab43a